Evidence map›Paper›PMID 12572869›Full record

Trial reportJournal of gastroenterology2002

Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial.

Osamu Kanauchi, Toshihiro Suga, Masahiro Tochihara, Toshifumi Hibi, Makoto Naganuma, Terasu Homma, Hitoshi Asakura, Hiroshi Nakano, Kazuya Takahama, Yoshihide Fujiyama and 10 more

Abstract readClinical TrialComparative StudyMulticenter Study
PubMed Publisher
In one paragraph

Trial report in Journal of gastroenterology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 5 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 5 syntheses or guidelines pooled it, 193 citations in OpenAlex.

  1. Pooled it
  2. Prebiotics for induction and maintenance of remission in ulcerative colitis.The Cochrane database of systematic reviews · 2024
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Effects of synbiotic therapy in mild-to-moderately active ulcerative colitis: A randomized placebo-controlled study.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2019
    Trial
  8. Trial
  9. The effects of an oral supplement enriched with fish oil, prebiotics, and antioxidants on nutrition status in Crohn's disease patients.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2011
    Trial
  10. Article
  11. Article
  12. Article
  13. Revolution in diet therapy for inflammatory bowel disease.JGH open : an open access journal of gastroenterology and hepatology · 2024
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. British Dietetic Association consensus guidelines on the nutritional assessment and dietary management of patients with inflammatory bowel disease.Journal of human nutrition and dietetics : the official journal of the British Dietetic Association · 2023
    Article
  19. Review
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 1 country.

Osamu KanauchiNutrient Food and Feed Division, Kirin Brewery, 10-1-2 Shinkawa, Chuo-ku, Tokyo 104-8288, Japan.
Toshihiro Suga
Masahiro Tochihara
Toshifumi Hibi
Makoto Naganuma
Terasu Homma
Hitoshi Asakura
Hiroshi Nakano
Kazuya Takahama
Yoshihide Fujiyama
Akira Andoh
Takashi Shimoyama
Nobuyuki Hida
Ken Haruma
Hideki Koga
Keiichi Mitsuyama
Michio Sata
Masanobu Fukuda
Atsushi Kojima
Tadao Bamba
Shiga University of Medical Science · JPFujita Health University · JPHyogo Medical University · JPKawasaki Medical School · JPKeio University · JPKirin (Japan) · JPKurume University · JPNiigata University · JPSapporo Kosei General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGerminated barley foodstuff (GBF) is a prebiotic foodstuff that effectively increases luminal butyrate production by stimulating the growth of protective bacteria. In the first pilot study, GBF has been shown to reduce both clinical activity and mucosal inflammation in ulcerative colitis (UC). The aim of this study was to investigate the efficacy of GBF in the treatment of UC in a multicenter open control trial.

methodsEighteen patients with mildly to moderately active UC were divided into two groups using a random allocation protocol. The control group (n = 7) were given a baseline anti-inflammatory therapy for 4 weeks. In the GBF-treated group (n = 11), patients received 20-30 g GBF daily, together with the baseline treatment, for 4 weeks. The response to the treatments was evaluated clinically and endoscopically. Fecal microflora were also analyzed.

resultsAfter 4 weeks of observation, the GBF-treated group showed a significant decrease in clinical activity index scores compared with the control group (P < 0.05). No side effects related to GBF were observed. GBF therapy increased fecal concentrations of Bifidobacterium and Eubacterium limosum.

conclusionsOral GBF therapy may have the potency to reduce clinical activity of UC. We believe that these results support the use of GBF administration as a new adjunct therapy for UC.

Indexed as

HordeumAdultBiopsy, NeedleColitis, UlcerativeColonoscopyDietary FiberFecesFemaleFollow-Up StudiesGerminationHumansIntestinal MucosaMaleMiddle AgedProbabilityReference ValuesDietary Fiber

Identifiers

PMID12572869
OpenAlexW2008793548

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.